KAREN MOSES: Open Payments
NPI 1093999054 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,115 in 95 payments from 35 companies in 2025. Trend: 2023 $2,090 · 2024 $2,800 · 2025 $2,115
Food & beverage: $2,019Education: $96
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $303 |
| AstraZeneca Pharmaceuticals LP | 9 | $168 |
| E.R. Squibb & Sons, L.L.C. | 8 | $149 |
| Novartis Pharmaceuticals Corporation | 7 | $129 |
| ABBVIE INC. | 7 | $125 |
| Celgene Corporation | 4 | $100 |
| Daiichi Sankyo Inc. | 4 | $96 |
| SOBI, INC | 4 | $85 |
| BeOne Medicines USA, Inc. | 3 | $70 |
| Genentech USA, Inc. | 3 | $62 |
Products named: RYBREVANT, REBLOZYL, DARZALEX, OPDIVO, Vonjo, Enhertu, IMFINZI, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
